Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,545 | 570 | 98.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $218.59 | 12 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $1,291 | 69 | $0 (2022) |
| ABBVIE INC. | $1,009 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $760.14 | 40 | $0 (2024) |
| Biogen, Inc. | $695.09 | 33 | $0 (2024) |
| GENZYME CORPORATION | $602.73 | 30 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $542.74 | 32 | $0 (2022) |
| Eisai Inc. | $509.40 | 35 | $0 (2024) |
| Lilly USA, LLC | $471.71 | 27 | $0 (2024) |
| UCB, Inc. | $454.28 | 23 | $0 (2023) |
| Genentech USA, Inc. | $395.84 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,397 | 68 | ABBVIE INC. ($213.00) |
| 2023 | $1,549 | 78 | AbbVie Inc. ($247.72) |
| 2022 | $1,348 | 70 | ABBVIE INC. ($322.16) |
| 2021 | $1,019 | 59 | AbbVie Inc. ($182.18) |
| 2020 | $789.54 | 45 | Supernus Pharmaceuticals, Inc. ($256.47) |
| 2019 | $1,780 | 93 | Supernus Pharmaceuticals, Inc. ($456.55) |
| 2018 | $1,593 | 93 | Supernus Pharmaceuticals, Inc. ($312.18) |
| 2017 | $1,288 | 76 | Teva Pharmaceuticals USA, Inc. ($162.43) |
All Payment Transactions
582 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: Neurology | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: EPILEPSY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Neurology | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: PAIN | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Neuropsychiatry | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Neurology | ||||||
| 08/15/2024 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: NEUROLOGY | ||||||
| 08/08/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $91.97 | General |
| Category: AMANTADINE | ||||||
| 08/08/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: PAIN | ||||||
| 08/07/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 960 | 1,194 | $286,790 | $129,266 |
| 2022 | 10 | 918 | 1,201 | $256,255 | $128,339 |
| 2021 | 9 | 896 | 1,183 | $250,980 | $128,418 |
| 2020 | 12 | 898 | 1,123 | $239,820 | $103,523 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 396 | 585 | $101,700 | $59,880 | 58.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 131 | 131 | $49,125 | $23,476 | 47.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 103 | 118 | $27,395 | $16,479 | 60.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 66 | 66 | $55,440 | $10,560 | 19.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 89 | 101 | $24,240 | $9,043 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,800 | $3,830 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 43 | $6,205 | $3,090 | 49.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 11 | 11 | $6,930 | $1,305 | 18.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 40 | 40 | $4,180 | $817.00 | 19.5% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 60 | 71 | $1,775 | $785.53 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 381 | 613 | $98,085 | $61,702 | 62.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 141 | 141 | $52,875 | $26,184 | 49.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 97 | 108 | $23,890 | $15,188 | 63.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 71 | 86 | $20,640 | $8,230 | 39.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 44 | 45 | $37,800 | $7,123 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 66 | $9,240 | $4,997 | 54.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,000 | $2,568 | 36.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 13 | 13 | $1,300 | $856.66 | 65.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 60 | 73 | $1,825 | $804.93 | 44.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 36 | 36 | $3,600 | $685.04 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 363 | 590 | $93,820 | $61,142 | 65.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 126 | 126 | $47,250 | $23,876 | 50.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 97 | 106 | $23,200 | $15,779 | 68.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 48 | 48 | $40,320 | $8,320 | 20.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 71 | 84 | $20,160 | $8,304 | 41.2% |
About Dr. Eric Czander, MD
Dr. Eric Czander, MD is a Neurology healthcare provider based in Arlington, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912997545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Czander, MD has received a total of $10,763 in payments from pharmaceutical and medical device companies, with $1,397 received in 2024. These payments were reported across 582 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,545).
As a Medicare-enrolled provider, Czander has provided services to 3,672 Medicare beneficiaries, totaling 4,701 services with total Medicare billing of $489,547. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Arlington, VA
- Active Since 10/25/2005
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1912997545
Products in Payments
- TROKENDI XR (Drug) $1,038
- APTIOM (Drug) $784.83
- UBRELVY (Drug) $652.87
- AUBAGIO (Drug) $625.61
- KESIMPTA (Drug) $513.49
- NURTEC ODT (Drug) $376.27
- EMGALITY (Drug) $364.64
- QULIPTA (Drug) $325.12
- VUMERITY (Drug) $270.48
- Fycompa (Drug) $262.75
- Vimpat (Drug) $253.02
- OXTELLAR XR (Drug) $252.47
- Leqembi (Drug) $228.18
- COPAXONE (Drug) $227.11
- TYSABRI (Biological) $205.77
- ACTHAR (Biological) $178.75
- Gocovri (Drug) $174.44
- Ocrevus (Biological) $164.76
- NAMZARIC (Drug) $149.26
- Briviact (Drug) $147.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Arlington
Dr. Dakota Schumacher, Md, MD
Neurology — Payments: $30,853
Dr. Dung Nguyen, M.d, M.D
Neurology — Payments: $16,481
Dr. Dung (Huy) Nguyen, M.d, M.D
Neurology — Payments: $15,430
Halim Fadil, M.d, M.D
Neurology — Payments: $12,128
Osman Mir, Md, MD
Neurology — Payments: $6,927
Margaret Perrin, M.d, M.D
Neurology — Payments: $3,620